Inventor

VAN SNICK JACQUES

BE25 patents

⚠️ This page may combine multiple inventors who share the name “VAN SNICK JACQUES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAN SNICK JACQUES

LUDWIG INST CANCER RES

T cell growth factor glycoproteins

Uses of substantially pure interleukin-9 receptor

Antibodies immunoreactive with the T-cell growth factor, P40

Substantially pure interleukin-9 receptor and uses thereof

Method for inhibiting production of IgE by using IL-9 inhibitors

Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof

Mage-A3 peptides presented by HLA class molecules

Method for enhanced growth and proliferation of mast cells

Method of treatment with IL-9 conjugate

MAGE-A1 peptides presented by HLA class II molecules

Methods for producing antibodies which specifically bind to interleukin-9 receptor

Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor

Process for preparing mammalian T cell growth factor P40

T cell growth factor

Method for regulating IL-10 with IL-9, and applications thereof

Method for regulating IL-10 with IL-9, and applications thereof

LUDWIG INST FOR CANCER RES LTD

TGF-β1 specific antibodies and methods and uses thereof

TGF-β1 specific antibodies and methods and uses thereof

TGF-ß1 specific antibodies and methods and uses thereof

TGF-β3 specific antibodies and methods and uses thereof

TGF-β3 specific antibodies and methods and uses thereof

TGF-β3 specific antibodies and methods and uses thereof

MEDIMMUNE INC

Recombinant anti-interleukin-9 antibodies

VAN SNICK JACQUES

TGF-β1 specific antibodies and methods and uses thereof

LUDWIG INSTITIUTE FOR CANCER R

Method for making cytokine specific antibodies and uses thereof